Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort
NCT ID: NCT01587456
Last Updated: 2016-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2012-04-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Evaluation of a Fracture Liaison Service
NCT06847776
Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort
NCT02606162
Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-Maritimes
NCT00821925
Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
NCT01250314
Resting-state Imaging and OSteoporosiS
NCT07030205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* medical history of low energy fracture
* DXA Tscore -2,5 DS
* FREE AND INFORMED CONSENT SIGNED
Exclusion Criteria
* Corticoids treatment
* Breast cancer or prostat cancer medical history
* High energy fracture (traumatic fracture)
* No social security affiliation
* Incapacity to informed consent signed.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georges WERYHA, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Brabois Endocrinology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Brabois Endocrinology
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00453-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.